“The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), recently established the COVID-19 Prevention Network (CoVPN). Its goal is to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19.”
“As part of this initiative, Oracle developed a Cloud System called the CoVPN Volunteer Screening Registry to identify and screen volunteers who want to participate in COVID-19 clinical trials. Even though the system has been live for less than a week, more than 100,000 people have already registered.”
“This program is expected to support hundreds of clinical trial sites across the United States and internationally by the end of the year. The trials are inclusive of absolutely everyone from all communities, with a focus on those who are at higher risk for COVID-19…” Read the full press release here.
Source: Oracle and NIH Collaborate on Cloud System to Support COVID-19 Vaccine Trials – July 16, 2020. Oracle.
